Shengnuo Biotechnology (688117.SH) announced that the company plans to invest 30 million yuan RMB to subscribe to 22.78% equity of Africa Bio Chem Co. Ltd. (referred to as the 'target company') in the United Republic of Tanzania (referred to as 'Tanzania') in East Africa...
Zhixin Finance and Economics APP News, Shengnuo Biotechnology (688117.SH) announced that the company plans to invest 30 million yuan RMB to subscribe to 22.78% equity of Africa Bio Chem Co. Ltd. (referred to as the 'target company') in the United Republic of Tanzania (referred to as 'Tanzania')...
The company's overseas investment in this matter meets the company's long-term planning and international strategic layout needs, which is conducive to further expanding the overseas market scale of the company's peptide products (obstetrics and gynecology, immune system, cardiovascular, diabetes, obesity and other fields), enhancing the company's core competitiveness in the overseas market, overall profit ability in the future, and positively promoting the company's sustained development in the future.
